Fleury

Fleury operates as one of Brazil’s largest healthcare organizations specializing in diagnostic medicine. It offers a broad range of laboratory and imaging exams, genomics services through its proprietary platform, infusion therapies for various conditions, telemedicine solutions via its digital health platform Saúde I, and specialized centers for child care and reproductive medicine. The company has recently expanded into precision medicine with advanced biomarker partnerships such as C₂N Diagnostics for Alzheimer’s disease detection[4]. It serves both B2C and B2B markets with over 245 million exams annually under multiple brands across Brazil[4][5][6].